Heiko E. von der Leyen

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

Heiko E. von der Leyen, Gary H. Gibbons, Ryuichi Morishita et al. · Proceedings of the National Academy of Sciences · 1995 · 768 citations · Full text

In Vivo Gene Therapy, Pathology, Vascular Tone +21

Expression of Inducible Nitric Oxide Synthase in Human Heart Failure

Guy A. Haywood, Philip S. Tsao, Heiko E. von der Leyen et al. · Circulation · 1996 · 493 citations

Cell Cycle Protein Expression in Vascular Smooth Muscle Cells In Vitro and In Vivo Is Regulated Through Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin

Ruediger C. Braun‐Dullaeus, Michael J. Mann, Ulrike Seay et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2001 · 134 citations · Full text

Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts.

Michael J. Mann, Gary H. Gibbons, Philip S. Tsao et al. · Journal of Clinical Investigation · 1997 · 117 citations · Full text

Vascular Disease, Engineering, Genetic Engineering Strategy +18

Cell Cycle–Dependent Regulation of Smooth Muscle Cell Activation

Ruediger C. Braun‐Dullaeus, Michael J. Mann, Daniel Sedding et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 64 citations · Full text